Changes in the Success and Characteristics of Tobacco Dependence Treatment before and during the COVID-19 Pandemic: Clinical Sample Comparisons

Author:

Stepankova Lenka1,Zvolska Kamila1,Pankova Alexandra12,Rafl Jakub3ORCID,Donin Gleb3ORCID,Tichopad Ales3ORCID,Kralikova Eva12

Affiliation:

1. Centre for Tobacco Dependent of the 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic

2. Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic

3. Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, 27201 Kladno, Czech Republic

Abstract

Background and Objectives: There is little information on changes in the process and outcomes of intensive tobacco dependence treatment during the COVID-19 pandemic. The following characteristics were evaluated: interest in treatment, the number of face-to-face or telephone follow-ups, the duration of pharmacotherapy use, and the success rate. The aim of our study was to compare the number of patients who entered tobacco dependence treatment programmes and evaluate the one-year success rate in patients three years before and three years after the COVID-19 pandemic. Materials and Methods: A single-site retrospective cohort study using data from patients treated at the Centre for Tobacco Dependence in Prague, Czech Republic, between 2017 and 2022 (n = 2039) was performed. The one-year abstinence rate was validated by measuring carbon monoxide in exhaled air (6 ppm cut-off). Patients were divided into two groups: the group for which treatment was initiated in 2017–2019 (i.e., before the COVID-19 pandemic, BC; n= 1221) and the group for which treatment was initiated in 2020–2022 (i.e., during the COVID-19 pandemic, DC; n = 818). Results: No significant differences in the success rate of tobacco dependence treatment were found between the two groups (BC group, 40.5% (494/1221) vs. DC group, 42.2% (345/818)) (χ2 (1, N = 2.039) = 0.6, p = 0.440). Furthermore, differences were not found in sex, education level, age at first cigarette, the duration of pharmacotherapy use, or the number of in-person visits. In contrast, there was an increase in the number of telephone contacts between the groups (18.7% (SD = 17.5%) vs. 32.9% (SD = 18.2%), p < 0.001). Conclusions: The number of patients who started treatment during the COVID-19 pandemic decreased by one-third compared to that during the 3-year period before the pandemic. The overall treatment success rate did not change significantly even with the increase in the number of telephone visits with the therapist.

Funder

Cooperatio Program, research area Metabolic Diseases

research area Health Sciences: Public Health, Hygiene and Epidemiology, Occupational Medicine

Publisher

MDPI AG

Reference44 articles.

1. (2008). Treating Tobacco Use and Dependence: 2008 Update U.S. Public Health Service Clinical Practice Guideline Executive Summary. Respir. Care, 53, 1217–1222.

2. Ofori, S., Lu, C., Olasupo, O.O., Dennis, B.B., Fairbairn, N., Devereaux, P.J., and Mbuagbaw, L. (2023). Cytisine for Smoking Cessation: A Systematic Review and Meta-Analysis. Drug Alcohol Depend., 251.

3. Doporučení pro Léčbu Závislosti Na Tabáku;Vnitř. Lékařství,2015

4. (2024, May 17). Policy Recommendations for Smoking Cessation and Treatment of Tobacco Dependence: Tools for Public Health. Available online: https://www.who.int/publications-detail-redirect/policy-recommendations-for-smoking-cessation-and-treatment-of-tobacco-dependence-tools-for-public-health.

5. The Double-Edged Relationship between COVID-19 Stress and Smoking: Implications for Smoking Cessation;Bommele;Tob. Induc. Dis.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3